Literature DB >> 22523285

Ionizing irradiation protection and mitigation of murine cells by carbamazepine is p53 and autophagy independent.

Hyun Kim1, Mark E Bernard, Amy Farkas, Julie Goff, Ronny Kalash, Frank Houghton, Donna Shields, Darcy Franicola, Tracy Dixon, Xichen Zhang, Michael Epperly, Hong Wang, Murat Can Cobanoglu, Joel S Greenberger.   

Abstract

BACKGROUND: Carbamazepine, a sodium channel blocker and pro-autophagy agent used in the treatment of epilepsy and trigeminal neuralgia, is also an ionizing radiation mitigator and protector.
MATERIALS AND METHODS: We measured the effect of carbamazepine, compared to other pro-autophagy drugs (i.e. lithium and valproic acid), on irradiation of autophagy incompetent (Atg5(-/-)) and competent (Atg5(+/+)) mouse embryonic fibroblasts, p53(-/-) and p53(+/+) bone marrow stromal cells, and human IB3, KM101, HeLa, and umbilical cord blood cell and in total body-irradiated or orthotopic tumor-bearing mice.
RESULTS: Carbamazepine, but not other pro-autophagy drugs, was a radiation protector and mitigator for mouse cell lines, independent of apoptosis, autophagy, p53, antioxidant store depletion, and class I phosphatidylinositol 3-kinase, but was ineffective with human cells. Carbamazepine was effective when delivered 24 hours before or 12 hours after total body irradiation of C57BL/6HNsd mice and did not protect orthotopic Lewis lung tumors.
CONCLUSION: Carbamazepine is a murine radiation protector and mitigator.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22523285      PMCID: PMC3335174     

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  46 in total

1.  A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles.

Authors:  S Paglin; T Hollister; T Delohery; N Hackett; M McMahill; E Sphicas; D Domingo; J Yahalom
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

2.  Two strategies for the development of mitochondrion-targeted small molecule radiation damage mitigators.

Authors:  Jean-Claude M Rwigema; Barbara Beck; Wei Wang; Alexander Doemling; Michael W Epperly; Donna Shields; Julie P Goff; Darcy Franicola; Tracy Dixon; Marie-Céline Frantz; Peter Wipf; Yulia Tyurina; Valerian E Kagan; Hong Wang; Joel S Greenberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-13       Impact factor: 7.038

3.  Radiosensitivity of human bone marrow granulocyte-macrophage progenitor cells and stromal colony-forming cells: effect of dose rate.

Authors:  T J FitzGerald; M McKenna; L Rothstein; C Daugherty; K Kase; J S Greenberger
Journal:  Radiat Res       Date:  1986-08       Impact factor: 2.841

Review 4.  Antiepileptic drug mechanisms of action.

Authors:  R L Macdonald; K M Kelly
Journal:  Epilepsia       Date:  1995       Impact factor: 5.864

5.  Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.

Authors:  Sushil Beriwal; Hayeon Kim; Dwight E Heron; Raj Selvaraj
Journal:  Technol Cancer Res Treat       Date:  2006-10

Review 6.  Autophagic pathways as new targets for cancer drug development.

Authors:  Bo Liu; Yan Cheng; Qian Liu; Jin-ku Bao; Jin-Ming Yang
Journal:  Acta Pharmacol Sin       Date:  2010-08-09       Impact factor: 6.150

7.  Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1.

Authors:  M Chiara Maiuri; Gaëtane Le Toumelin; Alfredo Criollo; Jean-Christophe Rain; Fabien Gautier; Philippe Juin; Ezgi Tasdemir; Gérard Pierron; Kostoula Troulinaki; Nektarios Tavernarakis; John A Hickman; Olivier Geneste; Guido Kroemer
Journal:  EMBO J       Date:  2007-04-19       Impact factor: 11.598

8.  Interleukin 3-dependent hematopoietic progenitor cell lines.

Authors:  J S Greenberger; R J Eckner; M Sakakeeny; P Marks; D Reid; G Nabel; A Hapel; J N Ihle; K C Humphries
Journal:  Fed Proc       Date:  1983-07

9.  Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.

Authors:  Giuseppe Minniti; Enrico Clarke; Gaetano Lanzetta; Mattia Falchetto Osti; Guido Trasimeni; Alessandro Bozzao; Andrea Romano; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2011-05-15       Impact factor: 3.481

10.  Strategies for discovery of small molecule radiation protectors and radiation mitigators.

Authors:  Joel S Greenberger; David Clump; Valerian Kagan; Hülya Bayir; John S Lazo; Peter Wipf; Song Li; Xiang Gao; Michael W Epperly
Journal:  Front Oncol       Date:  2012-01-13       Impact factor: 6.244

View more
  3 in total

1.  Multiparameter screening reveals a role for Na+ channels in cytokine-induced β-cell death.

Authors:  Yu Hsuan Carol Yang; Yury Y Vilin; Michel Roberge; Harley T Kurata; James D Johnson
Journal:  Mol Endocrinol       Date:  2014-01-17

2.  Evaluation of potential ionizing irradiation protectors and mitigators using clonogenic survival of human umbilical cord blood hematopoietic progenitor cells.

Authors:  Julie P Goff; Donna S Shields; Hong Wang; Erin M Skoda; Melissa M Sprachman; Peter Wipf; Venkata Krishna Garapati; Jeffrey Atkinson; Barry London; John S Lazo; Valerian Kagan; Michael W Epperly; Joel S Greenberger
Journal:  Exp Hematol       Date:  2013-08-07       Impact factor: 3.084

3.  The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells.

Authors:  Roberto Gomez-Casal; Chitralekha Bhattacharya; Michael W Epperly; Per H Basse; Hong Wang; Xinhui Wang; David A Proia; Joel S Greenberger; Mark A Socinski; Vera Levina
Journal:  Cancers (Basel)       Date:  2015-05-22       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.